GSK has turned to Brooke Shields to get the message out about shingles vaccination. | GSK has turned to Brooke Shields to get ...

UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Shingles Doesn't Care is a catchphrase that comes from part of a 30-second TV commercial for SHINGRIX, which is a vaccine for ...

The FDA’s clearance could double Kisqali’s breast cancer market. Elsewhere, Novo is exploring new ways to deliver genetic ...

GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects ... with Pfizer claiming commercial rights to the shingles shot in all territories other than BioNTech's home market ...

The stock fell 15% after the consumer goods firm swung to a loss of £96m for the 12 months to the end of May, against a £62m ...

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage ... the company's investigational vaccine candidate being developed for the prevention of shingles (herpes zoster), a ...

once Covid vaccines and therapeutics are moved onto commercial health platforms. According to The People’s Vaccine Alliance, Comirnaty costs an estimated $1.18 per dose to produce. For over two ...